Skip to content

Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study

Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02081144
Enrollment
60
Registered
2014-03-07
Start date
2014-05-31
Completion date
2014-10-31
Last updated
2020-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Tobacco Abstinence

Keywords

Standard Care Condition, Texting + NRT Condition

Brief summary

This is a pilot study to test the feasibility of conducting a text based smoking cessation trial with Emergency Department patients who are smokers.

Interventions

OTHERSmokefree TXT Program

The SmokeFreeTxt program is a library consisting of \ 130 brief messages that can be proactively sent to smokers' cellphones using software developed and maintained by NCI. The message content is informed by principles of cognitive behavioral therapy. They are sent to smokers at random times of day (during normal waking hours), up to 5 messages per day.

Subject will be given 4 weeks of Nicotine Replacement Patches, based on the amount he/she is smoking at baseline.

DRUGNicotine Replacement Gum

Subjects will be given 10 pieces of 2mg Nicotine Replacement Gum x 28 days.

BEHAVIORALFaxed Referral CT Smokers Quitline

A faxed referral will be sent to the CT Smokers Quitline for the subject.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
National Institutes of Health (NIH)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * have smoked \>= 100 cigarettes lifetime * describe themselves as every or some day smokers * are able to give written informed consent * reside in Connecticut * own a cell phone with texting capability.

Exclusion criteria

* inability to read or understand English * currently receiving formal tobacco dependence treatment * current use of tobacco cessation products (patch, gum, inhaler, nasal spray, lozenge, e-cigarette) * currently using Zyban (bupropion), Wellbutrin (bupropion) or Chantix (varenicline) for smoking cessation * current suicide or homicide risk * current psychotic disorder * life-threatening or unstable medical or psychiatric condition * does not have phone with CT area code and with texting capability * lacks capacity to give informed consent * leaving the ED against medical advice * pregnant, nursing, or trying to conceive * incarcerated * resides in an extended care facility

Design outcomes

Primary

MeasureTime frameDescription
Survey of satisfaction and usage of Smokefree TXT Program1 month post enrollmentStudy team will develop a survey to assess both subjects' satisfaction with the Smokefree TXT Program and ease of use.

Secondary

MeasureTime frameDescription
7 day point prevalence abstinence1 month post enrollment7 day point prevalence abstinence will be assessed by asking if the subject has smoked even a puff in the past 7 days.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026